Last10K.com

Hca Healthcare, Inc. (HCA) SEC Filing 10-K Annual Report for the fiscal year ending Sunday, December 31, 2023

SEC Filings

HCA Annual Reports

Hca Healthcare, Inc.

CIK: 860730 Ticker: HCA

Exhibit 99.1

 

LOGO

 

   FOR IMMEDIATE RELEASE
INVESTOR CONTACT:   

MEDIA CONTACT:

Frank Morgan   

Harlow Sumerford

615-344-2688   

615-344-1851

HCA HEALTHCARE REPORTS FOURTH QUARTER 2023 RESULTS

AND PROVIDES 2024 GUIDANCE

BILL RUTHERFORD TO RETIRE AND MIKE MARKS TO BECOME CFO

Nashville, Tenn., January 30, 2024 –

HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the fourth quarter ended December 31, 2023.

Key fourth quarter metrics (all percentage changes compare 4Q 2023 to 4Q 2022 unless otherwise noted):

 

   

Revenues totaled $17.303 billion

   

Net income attributable to HCA Healthcare, Inc. totaled $1.607 billion, or $5.93 per diluted share

   

Adjusted EBITDA totaled $3.618 billion

   

Cash flows from operating activities totaled $2.674 billion

   

Same facility admissions increased 3.1 percent while same facility equivalent admissions increased 3.9 percent

“In the quarter, we experienced strong demand for services across our diversified portfolio of markets, facilities, and service lines. This growth coupled with improved cost trends drove solid financial performance in the fourth quarter. Once again, our people have delivered positive outcomes for our patients, the communities we serve, and our other stakeholders. I want to thank them for their hard work and everything they do for our company,” said Sam Hazen, Chief Executive Officer of HCA Healthcare.

Revenues in the fourth quarter of 2023 totaled $17.303 billion, compared to $15.497 billion in the fourth quarter of 2022. Net income attributable to HCA Healthcare, Inc. totaled $1.607 billion, or $5.93 per diluted share, compared to $2.081 billion, or $7.28 per diluted share, in the fourth quarter of 2022. Results for the fourth quarter of 2023 include gains on sales of facilities of $7 million, or $0.03 per diluted share. Results for the fourth quarter of 2022 include gains on sales of facilities of $1.326 billion, or $2.64 per diluted share, related to sales of our controlling interests in certain healthcare entities.

 

1


The following information was filed by Hca Healthcare, Inc. (HCA) on Tuesday, January 30, 2024 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one year to another to evaluate Hca Healthcare, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Hca Healthcare, Inc..

Continue

Assess how Hca Healthcare, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Hca Healthcare, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2024 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Rating

Learn More
Bullish Bearish Neutral
Filter Sentiment:
All
Positive
Negative
Filter Category:
All
Financial
Legal
M & A
Revenue
Other
Filter Subcategory:
All
Cash Flow
Dividend
Expense
Debt
Product
Income
Shares
Earnings
Geography
Other
Inside Hca Healthcare, Inc.'s 10-K Annual Report:

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Cover Page
Consolidated Balance Sheets
Consolidated Balance Sheets (Parenthetical)
Consolidated Comprehensive Income Statements
Consolidated Income Statements
Consolidated Statements Of Cash Flows
Consolidated Statements Of Stockholders' Equity (Deficit)
Consolidated Statements Of Stockholders' Equity (Deficit) (Parenthetical)
Accounting Policies
Accounting Policies (Policies)
Accounting Policies (Tables)
Accounting Policies - Additional Information (Detail)
Accounting Policies - Schedule Of Estimated Cost Of Uncompensated Care (Detail)
Accounting Policies - Schedule Of Revenues From Third Party Payers, Uninsured And Other Payers (Detail)
Accrued Expenses
Accrued Expenses (Tables)
Accrued Expenses - Summary Of Other Accrued Expenses (Detail)
Acquisitions And Dispositions
Acquisitions And Dispositions - Additional Information (Detail)
Assets And Liabilities Measured At Fair Value
Assets And Liabilities Measured At Fair Value (Tables)
Assets And Liabilities Measured At Fair Value - Additional Information (Detail)
Assets And Liabilities Measured At Fair Value - Summary Of Investments Of Insurance Subsidiaries Measured At Fair Value On Recurring Basis (Detail)
Capital Stock
Capital Stock - Additional Information (Detail)
Contingencies
Earnings Per Share
Earnings Per Share (Tables)
Earnings Per Share - Additional Information (Detail)
Earnings Per Share - Schedule Of Computations Of Basic And Diluted Earnings Per Share (Detail)
Employee Benefit Plans
Employee Benefit Plans - Additional Information (Detail)
Financial Instruments - Effect Of Interest Rate Swaps On Results Of Operations (Detail)
Income Taxes
Income Taxes (Tables)
Income Taxes - Additional Information (Detail)
Income Taxes - Schedule Of Activity Related To Unrecognized Tax Benefits (Detail)
Income Taxes - Schedule Of Deferred Tax Assets And Liabilities (Detail)
Income Taxes - Schedule Of Provision For Income Taxes (Detail)
Income Taxes - Schedule Of Reconciliation Of Federal Statutory Rate To Effective Income Tax Rate (Detail)
Insider Trading Arrangements
Investments Of Insurance Subsidiaries
Investments Of Insurance Subsidiaries (Tables)
Investments Of Insurance Subsidiaries - Additional Information (Detail)
Investments Of Insurance Subsidiaries - Schedule Of Investments (Detail)
Investments Of Insurance Subsidiaries - Schedule Of Maturities Of Investments (Detail)
Leases
Leases (Tables)
Leases - Schedule Of Lease Expense For Finance And Operating Leases (Detail)
Leases - Schedule Of Lease-Related Assets And Liabilities (Detail)
Leases - Schedule Of Supplemental Cash Flow Information (Detail)
Leases - Schedule Of Undiscounted Cash Flows To The Finance Lease Liabilities And Operating Lease Liabilities (Detail)
Long-Term Debt
Long-Term Debt (Tables)
Long-Term Debt - Additional Information (Detail)
Long-Term Debt - Schedule Of Long-Term Debt (Detail)
Long-Term Debt - Schedule Of Long-Term Debt (Parenthetical) (Detail)
Other Comprehensive Loss
Other Comprehensive Loss (Tables)
Other Comprehensive Loss - Components Of Accumulated Other Comprehensive Loss (Detail)
Other Comprehensive Loss - Components Of Accumulated Other Comprehensive Loss (Parenthetical) (Detail)
Pay Vs Performance Disclosure
Segment And Geographic Information
Segment And Geographic Information (Tables)
Segment And Geographic Information - Additional Information (Detail)
Segment And Geographic Information - Schedule Of Geographic Distributions Of Revenues, Equity In Earnings Of Affiliates, Adjusted Segment Ebitda, Depreciation And Amortization, Assets And Goodwill And Other Intangible Assets (Detail)
Share-Based Compensation
Share-Based Compensation (Tables)
Share-Based Compensation - Additional Information (Detail)
Share-Based Compensation - Schedule Of Fair Value Of Each Stock Option Award Is Estimated On Grant Date, Using Option Valuation Models (Detail)
Share-Based Compensation - Schedule Of Restricted Stock Units Activity (Detail)
Share-Based Compensation - Schedule Of Stock Appreciation Rights Activity (Detail)
Ticker: HCA
CIK: 860730
Form Type: 10-K Annual Report
Accession Number: 0000950170-24-016524
Submitted to the SEC: Fri Feb 16 2024 5:03:58 PM EST
Accepted by the SEC: Fri Feb 16 2024
Period: Sunday, December 31, 2023
Industry: General Medical And Surgical Hospitals

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/hca/0000950170-24-016524.htm